Clomiphene Citrate for Women with Unexplained Infertility



Ovulation induction with clomiphene citrate (CC) alone or combined with intrauterine insemination (IUI), when indicated, is an effective and relatively inexpensive first line treatment for “unexplained infertility” due to suboptimal ovulation or cervical mucus factor, and may shorten the time to pregnancy by increasing the number of preovulatory follicles. Its most effective use will be in women older than 30 years because of the age-related decrease in antral follicles and in women with suboptimal ovulation as evidenced by low preovulation estrogen levels and low progesterone levels, or a short luteal phase. Outcomes are dependent on preovulatory follicle numbers and age of the female partner. Treatment should be continued for a maximum of four cycles except in women with ovulatory dysfunction where it may be continued for up to six cycles. Pregnancy rates can be improved and the risk of multiple pregnancies reduced by ultrasound and hormone monitoring.


Clomiphene citrate (CC) Controlled ovarian hyperstimulation (COH) Tamoxifen (TMX) Mid-luteal progesterone Preovulatory follicles Estradiol Cervical mucus Endometrial thickness Intrauterine insemination (IUI) Twins Triplets and higher order multiple pregnancies (HOMP) 


  1. 1.
    Dickey RP, Holtkamp D. Development, pharmacology, and clinical experience with clomiphene citrate. Hum Reprod Rev. 1996;2:485–506.CrossRefGoogle Scholar
  2. 2.
    Karande VC, Korn A, Morris R, Rao R, Balin M, Rinehart J, et al. Prospective randomized trial comparing the outcome and cost of in vitro fertilization with that of a traditional treatment algorithm as first-line therapy for couples with infertility. Fertil Steril. 1999;71:468–75.PubMedCrossRefGoogle Scholar
  3. 3.
    Guzick DS, Sullivan MW, Adamson GD, Cedars MI, Falk RJ, Peterson EP, Strinkampf MP. Efficacy of treatment for unexplained infertility. Fertil Steril. 1998;70:207–13.PubMedCrossRefGoogle Scholar
  4. 4.
    Practice Committee of the American Society for Reproductive Medicine. Effectiveness and treatment for unexplained infertility. Fertil Steril. 2006;86(Suppl 4):S111–4.Google Scholar
  5. 5.
    Deaton JL, Nakajima ST, Gibson M, Badger GJ, Blackmer KM, Brumsted JR. A randomized, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis. Fertil Steril. 1990;54:1083–8.PubMedGoogle Scholar
  6. 6.
    Collins JA, Milner RA, Rowe TC. The effect of treatment on pregnancy among couples with unexplained infertility. Int. J. Fertil. 1991;36:140–52.PubMedGoogle Scholar
  7. 7.
    Glazner CMA, Coulson C, Lambert PA, Watt EM, Hinton RA, Kelly NG, et al. Clomiphene treatment for women with unexplained infertility: placebo-controlled study of hormonal responses and conception rates. Gynecol Endocrinol. 1990;4:75–83.CrossRefGoogle Scholar
  8. 8.
    Hughes EG, Vandekerckhove P. Clomiphene citrate vs placebo or no treatment. In Unexplained subfertility. Oxford: BMJ Publishing Group, Cochrane Library; 1996. (Review number 0002).Google Scholar
  9. 9.
    Fujii S, Fukui A, Kagiya A, Sato S, Saito Y. The effects of clomiphene citrate on normally ovulatory women. Fertil Steril. 1997;68:997–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Hughes EG, Brown J, Collins JJ, Vandekerckhove P. Clomiphene citrate for unexplained infertility in women. Cochrane Database Syst Rev. 2010;20(CD000057):1–29.Google Scholar
  11. 11.
    Wordsworth S, Buchanan J, Mollison J, Harrild K, Robertson L, Tay C, et al. Clomiphene citrate and intrauterine insemination as first line treatments for unexplained infertility: are they cost-effective? Hum Reprod. 2011;36:369–75.CrossRefGoogle Scholar
  12. 12.
    Dickey RP, Taylor NN, Lu PY, Sartor MM, Pyrzak, R. Clomiphene citrate intrauterine insemination (IUI) before gonadotropin IUI affects the pregnancy rate and high order multiple pregnancy. Fertil Steril. 2004;81:545–50.PubMedCrossRefGoogle Scholar
  13. 13.
    Dickey RP. Strategies to reduce multiple pregnancies due to ovulation stimulation. Modern trends. Fertil Steril. 2009;91:1–17.PubMedCrossRefGoogle Scholar
  14. 14.
    Reindollar RH, Regan MM, Neumann PJ, et al. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast tract and standard treatment (FASTT) trial. Fertil Steril. 2010;94:888–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Furr BJA, Jordan VC. The pharmacology and clinical uses of tamoxifen. Pharmacol Ther. 1984;25:127–205.PubMedCrossRefGoogle Scholar
  16. 16.
    Mikkelson TJ, et al. Single-dose pharmacokinetics of clomiphene citrate in normal volunteers. Fertil Steril. 1986;46:392–6.PubMedGoogle Scholar
  17. 17.
    Kerin JF, Liu JH, Phillipou G, Yen SSC. Evidence for a hypothalamic site of action of clomiphene citrate in women. J Clin Endocrinol Metab. 1985;61:265–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Hsueh AJW, Erickson GF, Yen SSC. Sensitization of pituitary cells to luteinizing hormone releasing hormone by clomiphene citrate in vitro. Nature. 1978;273:57–9PubMedCrossRefGoogle Scholar
  19. 19.
    Dickey RP, Vorys N, Stevens VC, Hamwi G, Ullery JC. Observations on the mechanism of action of clomiphene (MRL 41). Fertil Steril. 1965;16:485–94.PubMedGoogle Scholar
  20. 20.
    Rossing MA, Daling JR, Weiss NS, et al. Ovarian tumors in a cohort of infertile women. N Engl J Med. 1994;331:771–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Schildkraut JM, Schwingle PJ, Bastos E, et al. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol. 1996;88:554–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Iqbal J, Ginsburg OM, Wijeratne D, Howekk A, Evans G, Sestak I, et al. Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review. Cancer Treat Rev. 2012;38:318–28.PubMedCrossRefGoogle Scholar
  23. 23.
    Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH, Pyrzak R. Relationship of follicle numbers and estradiol concentrations to multiple implantation of 3608 intrauterine insemination cycles. Fertil Steril. 2001;75:69–78PubMedCrossRefGoogle Scholar
  24. 24.
    Dickey RP, Taylor NN, Lu PY, Sartor MM, Rye PH, Pyrzak R. Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate-intrauterine insemination. Fertil Steril. 2002;78;1088–95.PubMedCrossRefGoogle Scholar
  25. 25.
    Dickey RP, Taylor SN, Rye PH, Lu PY, Pyrzak R. Comparison of sperm quality resulting in successful intrauterine insemination to world health organization threshold values for normal sperm. Fertil Steril. 1999;71:684–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Nakamura Y, Sugino N, Ono M, Ueda K, Yoshida Y, Kato H. Effects of clomiphene citrate on the endometrial thickness and echogenic pattern of the endometrium. Fertil Steril. 1997;67:256–60.PubMedCrossRefGoogle Scholar
  27. 27.
    Dickey RP, Olar TT, Taylor SN, Curole DN, Harrigill K. Relationship of biochemical pregnancy to preovulatory endometrial thickness and pattern in patients undergoing ovulation induction. Hum Reprod. 1993;8:327–30.PubMedGoogle Scholar
  28. 28.
    Vuorento T, Rarsula K, Hovatta O, Huhtaniemi I, Kurunmäki H. Measurements of salivary progesterone throughout the menstrual cycle in women suffering from unexplained infertility revel high frequency of luteal phase defects. Fertil Steril. 1990;54:211–6.PubMedGoogle Scholar
  29. 29.
    Finn MM, Goling JP, Tallon DF, Meehan FP, Fottrell PF. Follicular growth and corpus luteum function in women with unexplained infertility, monitored by ultrasonography and measurement of daily salivary progesterone. Gynecol Endocrinol. 1989;3:297–308.PubMedCrossRefGoogle Scholar
  30. 30.
    Rodin DA, Fisher AM, Clayton RN. Cycle abnormalities in infertile women with regular menstrual cycles: effects of clomiphene citrate treatment. Fertil Steril. 1994;62:42–7.PubMedGoogle Scholar
  31. 31.
    Randall JM, Templeton AT. Transvaginal sonographic assessment of follicular and endometrial growth in spontaneous and clomiphene citrate cycles. Fertil Steril. 1991;56:208–12.PubMedGoogle Scholar
  32. 32.
    Dickey RP. Evaluation and management of threatened and habitual first trimester abortion. In: Osofsky H, editor. Advances in clinical obstetrics and gynecology, vol. 2, Chap. 2. Chicago: Yearbook Medical Publishers; 1984. pp. 329–88.Google Scholar
  33. 33.
    Dickey RP, Hower JF. Effect of ovulation induction on uterine blood flow and oestradiol and progesterone concentrations in early pregnancy. Hum Reprod. 1995;10:2875–9.PubMedGoogle Scholar
  34. 34.
    Dickey RP. Doppler ultrasound investigation of uterine and ovarian blood flow in infertility and early pregnancy. Hum Reprod Rev. 1997;3:467–503CrossRefGoogle Scholar
  35. 35.
    Dickey RP, Gasser RF, Hower JF, Matulich EM, Brown GT. Relationship of uterine blood flow to chorionic and embryo growth rates. Hum Reprod. 1995;10:2676–9.PubMedGoogle Scholar
  36. 36.
    Strowitzki T, Germeyer A, Popovici R, von Wolff M. The human endometrium as a fertility-determining factor. Hum Repro Update. 2006;12:617–30.CrossRefGoogle Scholar
  37. 37.
    Dickey RP, Olar TT, Taylor SN, Curole DN, Matulich EM. Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: effect of clomiphene citrate alone and with human menopausal gonadotropin. Fertil Steril. 1993;59:756–60.PubMedGoogle Scholar
  38. 38.
    Benda JA. Clomiphene’s effect on endometrium in infertility. Int J Gynecol Path. 1992;11:273–82.CrossRefGoogle Scholar
  39. 39.
    Bonhoff AJ, Naether OGJ, Johannisson E. Effects of clomiphene citrate stimulation on endometrial structure in infertile women. Hum Reprod. 1996;11:844–9PubMedCrossRefGoogle Scholar
  40. 40.
    Randall JM, Templeton A. The effects of clomiphene citrate upon ovulation and endocrinology when administered to patients with unexplained infertility. Hum Reprod. 1991;6:659–64PubMedGoogle Scholar
  41. 41.
    Lamb EJ, Guderian AM. Clinical effects of clomiphene in anovulation. Obstet Gynecol. 1966:28:505–12.PubMedGoogle Scholar
  42. 42.
    Graff G. Suppression of cervical mucus during clomiphene therapy. Fertil Steril. 1971;22:209–12.PubMedGoogle Scholar
  43. 43.
    Diamond MP, Maxon WS, Vaughn WK, Osteen KG, Wentz AG. Antioestrogen effect of clomiphene citrate in a multiple follicular stimulation protocol. J In Vitro Fertil Embryo Transfer. 1986;3:106–9.CrossRefGoogle Scholar
  44. 44.
    Check JH, Davis E, Adelson H. A randomized prospective study comparing pregnancy rates following clomiphene citrate and human menopausal gonadotrophin therapy. Hum Reprod. 1992;7:801–5.PubMedGoogle Scholar
  45. 45.
    Randall JM, Templeton A. Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles. Fertil Steril. 1991;56:465–8.PubMedGoogle Scholar
  46. 46.
    Thompson LA, Burratt CLR, Thornton SJ, Bolton AE, Cooke ID. The effects of clomiphene citrate and cyclofenil on cervical mucous volume and receptivity over the periovulatory period. Fertil Steril. 1993;59:125–9.PubMedGoogle Scholar
  47. 47.
    Acharya U, Irvine DS, Hamilton MPR, Templeton AA. The effect of three anti-oestrogen drugs on cervical mucus quality and in-vitro sperm-cervical mucus interaction in ovulatory women. Hum Reprod. 1993;8:437–41.PubMedGoogle Scholar
  48. 48.
    Annapurna V, Dhaliwal LK, Gopalan S. Effect of two anti-estrogens, clomiphene citrate and tamoxifen, on cervical mucus and sperm-cervical mucus interaction. Int J Fertil. 1997;42:215–8.Google Scholar
  49. 49.
    Dickey RP, Brinsden PR, Pyrzak R, editors. Manual of intrauterine insemination and ovulation induction. Cambridge: Cambridge University Press; 2010. p. 19–30.Google Scholar
  50. 50.
    Oei SG, Helmerhost EM, Kerise MJN. When is the postcoital test normal? A critical appraisal. Hum Reprod. 1995;10:1711–4.PubMedGoogle Scholar
  51. 51.
    Roumen JME, Desbur WH, Rolland R. Treatment of infertile women with a deficient post coital test with two antiestrogens, clomiphene and tamoxifen. Fertil Steril. 1984;41:237–43.PubMedGoogle Scholar
  52. 52.
    Buvat J, Buvat Herbaut M, Marcolin G, Ardaens Boulier K. Antiestrogens as treatment of female and male infertilities. Horm Res. 1987;28:219–29.PubMedCrossRefGoogle Scholar
  53. 53.
    Tepper R, Luenfeld B, Shalev J, Ovadia J, Blankstein J. The effect of clomiphene citrate and tamoxifen on the cervical mucus. Acta Obstet Gynecol Scand. 1988;67:311–4.PubMedCrossRefGoogle Scholar
  54. 54.
    Maxson WS, Pittaway DE, Hebert CM, Garner CH, Wentz AC. Antiestrogenic effect of clomiphene citrate: correlation with serum estradiol concentrations. Fertil Steril. 1984;41:356–9.Google Scholar
  55. 55.
    Gelert TJ, Buyalos RP. The effect of clomiphene citrate and menopausal gonadotropins on cervical mucus in ovulatory cycles. Fertil Steril. 1993;60:471–6.Google Scholar
  56. 56.
    Blasco L. Clinical approach to the evaluation of sperm cervical interactions. Fertil Steril. 1977;28:1133.PubMedGoogle Scholar
  57. 57.
    Check JH, Adelson HG, Wu CH. Improvement of cervical factor with guaifenesin. Fertil Steril. 1982;37:707–8PubMedGoogle Scholar
  58. 58.
    Dickey RP, Taylor SN, Lu PY, Sartor BM, Dunaway HE. Can the number of antral follicles before the start of gonadotropin stimulation predict the number of preovulation follicles and total oocytes in IVF cycles? P-600. Fertil Steril. 2010;97:S266.CrossRefGoogle Scholar
  59. 59.
    Dickey RP, Bordson BL, Taylor SN, Curole DN, Dunaway HE. Micronized oral progesterone for luteal phase support in IVF. Abstracts of the scientific paper and poster session. The American Fertility Society; 1986:53.Google Scholar
  60. 60.
    Fisch P, Collins JA, Casper RE, Reid RL, Brown SE, Simpson C, et al. Unexplained infertility: evaluation of treatment with clomiphene and human chorionic gonadotropin. Fertil Steril. 1989;51:828–33.PubMedGoogle Scholar
  61. 61.
    Beck JI, Boothroyd C, Proctor M, Farquhar C, Hughes E. Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation. Cochrane Database Syst Rev. 2005;25(1):CD002249.Google Scholar
  62. 62.
    Parsanezhad ME, Albozi S, Motazedian S, Omrani G. Use of dexamethasone and clomiphene citrate in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome and normal dehydroepiandrosterone sulfate levels; a prospective, double-blind, placebo-controlled trial. Fertil Steril. 2002;78:1001–4.PubMedCrossRefGoogle Scholar
  63. 63.
    Siebert TI, Kruger TF, Steyn DW, Nosarka S. Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review. Fertil Steril. 2006;78:1001–4.Google Scholar
  64. 64.
    Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, et al. Clomiphene, metformin or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007;356:551–6.PubMedCrossRefGoogle Scholar
  65. 65.
    Crosignani PG, Collins J, Cooke ID, Diczfalusy E, Rubin B. Unexplained infertility. Hum Reprod. 1993;8(6):977–80.PubMedGoogle Scholar
  66. 66.
    Hughes E, Brown J, Collins JJ, Vanderkerchove P. Clomiphene citrate vs. placebo for ovulation induction in oligo-amenorrhoeic women. Cochrane Database Syst Rev. 1996;22(1):CD000056.Google Scholar
  67. 67.
    Steiner AZ, Terplan M, Paulson RJ. Comparison of tamozifen and clomiphene citrate for ovulation induction: a meta-analysis. Hum Reprod. 2005;20:1511–5.PubMedCrossRefGoogle Scholar
  68. 68.
    Custers IM, Steures P, Hompes P, Flierman P, van Kasteren Y, van Dop PA, van der Veen F, Mol Ben WJ. Intrauterine insemination: how many cycles should we perform? Hum Reprod. 2008; 23:885–8.PubMedCrossRefGoogle Scholar
  69. 69.
    Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH, Pyrzak R. Risk factors for high-order multiple pregnancy and multiple birth after controlled ovarian hyperstimulation: results of 4,062 intrauterine insemination cycles. Fertil Steril. 2005;83:671–83.PubMedCrossRefGoogle Scholar
  70. 70.
    Dickey RP. A year of inaction on high-order multiple pregnancies due to ovulation induction. Fertil Steril. 2003;79:14–6PubMedCrossRefGoogle Scholar
  71. 71.
    Dickey RP, Xoing X, Gee RE, Pridjian G. Effect of maternal height and weight on risk of preterm birth in singleton and twin births resulting from IVF: a retrospective cohort study using SART-CORS. Fertil Steril. 2012;97:249–54.CrossRefGoogle Scholar
  72. 72.
    Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Mathews TJ, Osterman MJ. Births: final data for 2009. Natl Vital Stat Rep. 2011;60:1.PubMedGoogle Scholar
  73. 73.
    Mathews TJ, MacDorman MF. Infant mortality statistics from the 2007 period linked birth/infant death data set. Natl Vital Stat Rep. 2011;59:6. (Table D).Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2015

Authors and Affiliations

  1. 1.The Fertility InstituteMandevilleUSA

Personalised recommendations